The primary structure of glycoprotein B (gB) is conserved strongly among many members of the Herpesviridae, including some that differ vastly in their natural properties. To determine whether the structural similarity between the gBs of herpes simplex virus type I (HSV-1) and bovine herpesvirus type 1 (BHV-1) was reflected in functional homology, we constructed pseudodiploid HSV-1 virions which, in addition to their own gene encoding gB, also contained a gene for encoding BHV-1 gB. Two kinds of pseudodiploid viruses were constructed. In one, the coding sequences of the BHV-1 gB gene were linked to the 5' flanking sequences of the HSV-1 thymidine kinase (TK) gene. In the other, the entire BHV-1 gB gene, including its own flanking sequences, was introduced into the TK gene. In cells infected with the viruses both HSV-1 and BHV-1 gB were made but they could be distinguished immunologically by monoclonal antibodies. Both glycoproteins were inserted into cellular and virion membranes but did not form oligomers with each other. A monoclonal antibody that binds to HSV-1 gB but not BHV-1 gB neutralized the parental HSV-1 and a revertant pseudodiploid virus from which the gene encoding BHV-1 gB had been excised, but was significantly less efficient at neutralizing the pseudodiploid viruses. This suggests that the BHV-1 homologue can complement the HSV-1 gB functions required for infectivity.
Introduction
Homologues of the herpes simplex virus glycoprotein B (gB) have been discovered in every herpesvirus examined to date and the genes for many of these glycoproteins have been cloned and sequenced [herpes simplex virus type 1 (HSV-1), Bzik et al., 1986; Pellett et al., 1985b; McGeoch et al., 1988; HSV-2, Stuve et al., 1987; human cytomegalovirus, Cranage et al., 1986; varicellazoster virus, Keller et al., 1986; Epstein-Barr virus, Baer et al., 1984; Pellett et al., 1985a; Gong et al., 1987 ; bovine herpesvirus type-1 (BHV-1), Misra et al., 1988; Whitbeck et al., 1988; BHV-2, Hammerschmidt et al. , 1988; pseudorabies virus, Robbins et al., 1987 ; equine herpesvirus type 4 (EHV-4), Riggio et al., 1989; EHV-1, Whalley et al., 1989; Marek's disease virus, Ross et al., 1989 ; herpesvirus saimiri, Albrecht & Fleckenstein, 1990] . Although homologues for other HSV proteins exist among members of the Herpesviridae, gB, and to a lesser extent gH, are the only glycoproteins that exhibit a significant degree of structural conservation and immunological cross-reactivity (Davison & Taylor, 1987; Misra et al., 1988) .
Although HSV-I gB has been implicated in the attachment to and penetration of the host cell membrane by the virus (Cai et al., 1988b; DeLuca et al., 1982; Highlander et al., 1988; Manservigi et al., 1977; Sarmiento et al., 1979) , its conserved nature suggests that it may have other functions as well.
To determine the role that gB plays in the biology of herpesviruses, a number of mutants with defects in the functional domains of gB are required. However, an operative gB is essential for the replication of the virus and so isolation of mutants has been difficult. Cai et al. (1987) , using a cell line that produces gB to complement lethal defects in mutants, isolated a gB-null virus. They have used this mutant, very effectively, to identify some structural and functional domains of gB (Cai et al., 1988a, b; Highlander et al., 1988) . In the course of their investigations, Cai et al. (1988a) discovered that wildtype (W ÷) gB is inhibited by mutant gB polypeptides which presumably form inactive oligomers with the W ÷ glycoprotein. This makes it difficult to use the gBproducing cell line to isolate mutants other than null mutants. Mutants can, therefore, be analysed only in cotransfection assays. Although this does allow expres-0000-9954 © 1991 SGM sion of the mutants in the context of other viral proteins in the infected cell, the mutant gene cannot be examined as an integral part of the virus.
An alternative approach to studying the function of gB may be to rely upon the ability of homologous, yet immunologically distinguishable, proteins from related herpesviruses to complement mutations in this essential gene. This strategy would make it possible to change one copy of the gene while permitting the virus to use the other to fulfil its vital requirements. The intact gene may then be blocked selectively to examine the effects of the changes in the other copy on the phenotype of the virus and the infected cell. Recently, we (Misra et al., 1988) and Whitbeck et al. (1988) demonstrated that the BHV-1 gB, also called gI or GVP6-11-16, is structurally very similar to HSV-1 gB. The two proteins share many features that are thought to be important for the function of HSV-1 gB and its interaction with other viral proteins. Yet, although BHV-1 gB can be expected to complement HSV-1 gB, these homologous glycoproteins can be distinguished by monoclonal antibodies (MAbs).
We have constructed two 'pseudodiploid' HSV-1 viruses which, in addition to containing the indigenous gene encoding gB, also have the gene encoding BHV-1 gB. Although the pseudodiploid viruses incorporate both glycoproteins in the membranes of virions and infected cells, the homologues do not form oligomers with each other.
Methods
Virus and cell culture. The P8-2 strain of BHV-1 has been studied in our laboratory for a number of years. Details of its cultivation in Madin-Darby bovine kidney (MDBK) cells and of its purification in potassium tartrate gradients have been described (Misra et al., 1982a; Nelson et al., 1989) . The antimutator strain of HSV-1 (PAAr5) was obtained from Dr D. Coen (Harvard University, Cambridge, Mass., U.S.A.) and was grown and purified as described for BHV-1.
Monoclonal antibodies, immunoprecipitation and PAGE.
The anti-BHV-1 gB MAb VH 12 and details of immunoprecipitation and PAGE have been described (Misra et al., 1982b; Nelson et al., 1989) . The anti-HSV-1 gB MAb, H233 (Pereira et al., 1981 (Pereira et al., , 1989 , was obtained from Dr L. Pereira (University of San Francisco, Ca., U.S.A.). [supE, thi, (lac-proAB) , (F', traD36, pAB, laclq) ZM15] (Yanisch-Perron et al., 1985) and E. coli RZ1032 dutl, ungl, thil, relA1 ] (Kunkel, 1985) were the host strains used for all recombinant plasmids and were grown in YT broth.
Plasmids and strains. Escherichia coli JMI01
The plasmid pl9BHVgB consists of a 3-6 kb HpaI-KpnI fragment of BHV-1 DNA cloned into the HinclI-KpnI site of pEMBL19 4- (Dente et al., 1983) . The HinclI-KpnI fragment contains the entire coding sequence of the BHV-1 gB gene as well as 378 bp of its 5', and 416 bp of its 3', flanking sequences; the nucleotide sequence of the HinclI KpnI fragment has been described (Misra et al., 1988) . The plasmid pHSV106, which consists of a 3.6kb BamHI-BamHI fragment containing the thymidine kinase (TK) gene of HSV-1 cloned into pBR322, was obtained from Dr S. McKnight (Carnegie Institute, Baltimore, Md., U.S.A.). The sequence of the TK coding sequences has been published (McKnight, 1980) . Cloning and analysis of DNA fragments. DNA fragments were cloned and analysed by agarose gel electrophoresis essentially as described by Maniatis et al. (1982) . All enzymes used in cloning experiments were purchased from BRL/Gibco and used according to the manufacturer's specifications.
Oligonucleotide directed mutagenesis. A 48 base oligonucleotide which was homologous to the nucleotide sequence immediately upstream of the putative initiation codon of BHV-1 gB, except for insertion of a BlgII site, was synthesized on an Applied Biosystems model 380A DNA synthesizer (Biotechnology Laboratory, University of British Columbia, Vancouver, Canada). This oligonucleotide was used in priming in vitro synthesis of the complementary strand (Zoller & Smith, 1982) of pl9BHVgB which had previously been passed through RZ1032, a dut-ung-strain of E. coli (Kunkel, 1985) . The reaction mixture was then introduced into E. coli strain JM101 and plasmidcontaining colonies were selected on medium containing 100 Ixg ampicillin/ml. Plasmid DNA from colonies was purified by the minipreparation method (Maniatis et al., 1982) and analysed for the presence of a BgllI site at the correct location by electrophoresing restriction endonuclease digests of the DNA on agarose gels.
Recombination. Viral DNA for transfection was prepared by a method which was modified from that of Smiley et al. (1981) . Four 100 mm diameter tissue culture dishes of Vero cells were infected with HSV-1 at an m.o.i, of 1 p.f.u./cell. The cells were collected 2 days later, resuspended in 4ml TNE buffer (0.01 M-Tris-HCI pH 7.5, 0.15 MNaC1, 0.001 ~i-EDTA) and SDS and proteinase K were added to final concentrations of 0.5 % and 400 ~tg/ml, respectively. After incubation for 4 h at 37 °C, the solution was extracted once with an equal volume of phenol:chloroform (1:1) and dialysed extensively against sterile 0.1 x SSC and deionized water. This DNA preparation was called HSV-Vero DNA and 50 pl of this DNA solution produced 500 to 1000 plaques/60 mm diameter plate.
Vero cells were transfected using a CellPhect (Pharmacia) transfection kit as suggested by the manufacturer. Precipitates containing 50 ~tl HSV-Vero DNA alone or HSV-Vero DNA mixed with 15 ~tg BamHIrestricted plasmid DNA were added to Vero cells in 60 mm diameter tissue culture dishes. Ceils were harvested for virus 3 to 5 days after transfection.
Virus from recombination experiments was assayed for p.f.u, in the presence and absence of 20 ~tg bromovinyl deoxyuridine (BVdU; obtained from Dr S. Gupta of this University). Virus harvested from transfections without plasmid DNA survived in BVdU with a frequency of less than 10 -4 whereas virus from transfections in which plasmid DNA had been added to HSV-Vero DNA produced 10-fold more BVdU-resistant plaques. To isolate BVdU-resistant mutants, 104 to l0 s p.f.u, virus was used to infect Vero cells in 60 mm diameter plates. The cells were then overlaid with med~m containing 0.5% agarose and 20 v-g BVdU/ml; additional medium containing 0.01% neutral red was added 2 days later. The next day isolated plaques were transferred to Vero cells in 24-well plates. Recombinant viruses, described in this communication, were twice purified from isolated plaques.
The gene encoding BHV-1 gB was removed from the pseudodiploid viruses by homologous recombination with an intact TK gene. Viral DNA, mixed with linearized pHSV106, was introduced into Vero cells. Virus containing functional TK was enriched by passaging twice through LTK-cells in the presence of HAT medium (Littlefield, 1964) . Virus, propagated from isolated plaques on Vero ceils, was then assayed for sensitivity to BVdU and the inability to synthesize BHV-1 gB.
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Analysis of mini-preparations of viral DNA. Vero cells in 60 mm
diameter dishes were infected with virus at an m.o.i, of approximately 1 p.f.u./cell. The cells were scraped and collected by centrifugation 2 days after infection and the supernatant was saved. The cells were resuspended in 1 ml distilled water and disrupted by sonication. After removal of the cell debris the superuatant was combined with the cellfree tissue culture fluid and layered on a 1 m130~ sucrose cushion. The virus was then pelleted through the cushion at 60000g for 1 h. The viral pellet was resuspended in 150 ~tl TE buffer (0-01 M-Tris-HC1 pH 7-5, 0.001 M-EDTA), lysed with 0-1 ~ SDS and extracted successively with phenol, phenol:chloroform (1:1), chloroform and ether.
Small-scale preparations of DNA (25 ~tl) was cut with BamHI and the fragments were separated on an agarose gel and transferred to a nylon membrane (Hybond-N; Amersham). The blots were probed with an isolated DNA fragment containing the gene encoding BHV-1 gB labelled with 32p by the random primer extension method (Feinberg & Vogelstein, 1983; Misra et al., 1988) .
Neutralization of virus infectivity by MAbs. Virus (100 to 200 p.f.u.) was incubated at 37 °C for 30 min in the presence or absence of serially diluted ascites fluid containing HSV-1 gB-specific MAb. The virusantibody mixture was then added to cells in 1.5 cm diameter wells of tissue culture dishes. After allowing virus to attach for 60 min, the inoculum was replaced with medium containing 0.5~ agarose. Viral plaques were counted 72 h later, after staining of viable cells with neutral red.
Results

HSV-1 and BHV-1 gBs can be distinguished immunologically
To demonstrate that M A b s VH12 and H233 could distinguish between HSV-1 gB and BHV-1 gB, lysates of cells infected with either HSV-1 or BHV-1 were immunoprecipitated with the two M A b s (Fig 1) . The antibody directed against BHV-1 gB immunoprecipitated BHV-1 gB, as well as its 74K and 55K cleavage products, from BHV-l-infected M D B K cells but it did not react with any proteins synthesized in HSV-1-infected Vero cells. M A b H233 immunoprecipitated the various forms and associated low Mr peptides of HSV-1 gB (Pereira et al., 1982) but it did not react with proteins from BHV-l-infected cells.
Insertion of the gene encoding BHV-1 gB into the cloned TK gene of HSV-1
In our experience BHV-1 genes are not trans-activated efficiently in HSV-l-infected cells. To overcome this problem we replaced the 5' flanking sequences of BHV-1 gB with those of the HSV-1 T K gene. In HSV-1 T K a unique BgllI site lies 52 nucleotides downstream from the transcription start site (McKnight, 1980) . We therefore introduced a BgllI site five nucleotides 3) . The immunoprecipitates were then analysed by SDS-PAGE.
upstream of the putative initiation codon of BHV-1 gB (Misra et al., 1988) . The BgllI-KpnI fragment, containing the entire coding sequence of the BHV-1 gB gene as well as 416 nucleotides of the 3' flanking sequences ( Fig. 2) was then inserted between the BgllI and KpnI sites of the T K gene (Fig. 2) ; this plasmid was called pTKgB2. , 1988) , which overlaps the reading frame of the T K gene. Although the function of the protein encoded by UL24 is not known, it is apparently required for the efficient replication of HSV-1 (Jacobson et al., 1989) . To avoid secondary effects due to the interruption of UL24 we constructed another plasmid in which the entire 3-57kb HinclI-KpnI insert from p 19BHVgB was inserted between the SacI and KpnI sites of the T K gene (Fig. 2) ; this plasmid was called p T K g B 1.
Construction of the pseudodiploid viruses
To insert the gene encoding BHV-1 gB into HSV-1 D N A , Vero cells were transfected with HSV-Vero D N A to which either pTKgB1 or p T K g B 2 had been added.
The plasmids were cut with BamHI and purified before transfection. Virus harvested from the transfections was then screened for the T K -phenotype by its ability to The Bglll-Kpnl fragment containing the coding region of BHV-1 gB was cloned between the BgllI and KpnI sites of pHSV106 to yield pTKgB2 whereas the HinclI-KpnI fragment of pBHVgB was cloned between the SacI and Kpnl sites within UL23 to yield pTKgB1. The SacI site, lost during the construction, is bracketed. Linearized pTKgB1 and pTKgB2 were transfected into cells with HSV-1 DNA to produce PsBHVgB-I and PsBHVgB-2 respectively. form plaques in the presence of BVdU; BVdU-resistant virus was plaque-purified again. D N A from BVdUresistant clones was then cut with BamHI and analysed for the presence of the BHV-1 gB gene by Southern blot hybridization (Fig. 3) .
A radioactive HinclI-KpnI fragment containing the BHV-1 gB gene hybridized faintly to an 8 kb HSV-1 fragment, which probably contained the gene encoding HSV-1 gB, as well as to a 3-6 kb fragment. It hybridized much more strongly to homologous sequences in the 7-0 kb and 6.2 kb fragments of pTKgB1 and pTKgB2. All six recombinants derived from pTKgB1 and two of five derived from pTKgB2 had the appropriately sized BamHI fragments displaying strong hybridization. 
Synthesis of BHV-1 gB by recombinants
To determine whether recombinant HSV-1 could synthesize BHV-1 gB, Vero cells were infected with either HSV-1 or the recombinants and labelled with [35S]methionine. BHV-1 gB was then immunoprecipitated from the cell lysates with MAb VH 12. All recombinant HSV-1 shown to contain BHV-1 gB gene sequences synthesized BHV-1 gB (130K Mr) and its cleavage products, GVPI 1 (74K) and GVP16 (55K). Recombinants derived from pTKgB2, in which the gene encoding BHV-1 gB is linked to the T K gene promoter, produced more BHV-1 gB than recombinants derived from pTKgB1, in which the synthesis of the glycoprotein is probably controlled by its own promoter. Two recombinants were purified from isolated plaques and propagated for further study. These pseudodiploid HSV-I will be called PsBHVgB-1 and PsBHVgB-2 after the plasmids from which they were derived. Fig. 4 depicts the relative amounts of gB homologues synthesized in cells infected with HSV-1 and the two pseudodiploid viruses.
Is BHV-1 gB incorporated into recombinant virions ?
Most, if not all, proteins that are incorporated into herpes virion membranes are of viral origin. This suggests that viral proteins that are to be incorporated within virion membranes have signals that direct them to their destination. To determine whether these signals are conserved between the two gB proteins we examined PsBHVgB-I and PsBHVgB-2 virions for the presence of both proteins. M D B K cells were infected with the two pseudodiploid viruses, the cells were then labelled with [35S]methionine and 24 h after infection virions from the cultures were harvested and purified by differential 4) were partially purified by differential centrifugation and banding in potassium tartrate gradients. The virion membranes were solubilized, BHV-I gB and HSV-I gB were immunoprecipitated with MAbs VH12 (lanes 1 and 3) or H233 (lanes 2 and 4) and analysed by SDS-PAGE. The radioactivity associated with a portion of the immunoprecipitates was measured by liquid scintillation counting.
centrifugation and on potassium tartrate gradients. Although the level of purity of these virions was not established, we have previously demonstrated that this procedure yields BHV-1 virions (Misra et al., 1982a) that are free of detectable non-structural proteins. The virion membranes were then solubilized and the two glycoproteins immunoprecipitated with MAbs VH12 and H233 (Fig. 5) . The ratio of radioactivity associated with BHV-1 gB and HSV-1 gB was comparable in immunoprecipitates of cell lysates and virions of each pseudodiploid virus. This suggested that the extent of incorporation of each homologue into virions was related to the level of its synthesis in the infected cells. HSV-1 gB and BHV-1 gB form homo-oligomers that are resistant to disruption under the conditions used in the immunoprecipitation assay (Claesson-Welsh & Spear, 1986; Sarmiento et al., 1979) . Our results showed that the gB homologues do not form a detergent-resistant association with each other as hetero-oligomers. Although the intact molecules of the two gB homologues have similar electrophoretic mobilities and are difficult to differentiate, no BHV-1 gB cleavage products were detected, even after extended exposure of X-ray films, in HSV-1 gB immunoprecipitated from pseudodiploid virions or from cells infected with the pseudodiploid viruses; similarly, BHV-1 gB immunoprecipitates did not appear to contain HSV-1 gB. The inability of the MAbs to coprecipitate the two gB glycoproteins from the pseudodiploid virus-infected cells or virions indicates that the two glycoproteins do not form oligomers with each other.
Can the BHV-1 gB incorporated into pseudodiploid virions function in infection ?
HSV-I gB has been shown to play a role in the early stages of the infectious process and is thought to facilitate penetration of the host cell membrane. To determine whether BHV-1 gB incorporated into the pseudodiploid virion membrane could perform this function the ability of MAb H233 to neutralize HSV-1 PAAr5, PsBHVgB-1, PsBHVgB-2 and BHV-1 was examined (Fig. 6) . MAb H233 does not bind to BHV-1 gB and did not neutralize BHV-1; however, at high concentrations, it completely neutralized HSV-1 PAA*5 and neutralized half the input virus at a dilution of 1:1500, the lowest concentration tested. The MAb was less efficient at neutralizing PsBHVgB-1 and, at high concentrations of antibody, only marginally inactivated PsBHVgB-2, which expresses equivalent amounts of the two gB homologues. The difference between the neutralization kinetics of HSV-1 PAAr5 and the pseudodiploid HSVs may reflect the ability of BHV-1 gB to initiate infection in the presence of neutralized HSV-1 gB. An alternative explanation may be that during the construction of the pseudodiploid viruses, variants of HSV-I gB, less susceptible to neutralization by MAb H233, may have been selected. To distinguish between these possibilities the gene for BHV-1 gB was excised from HSVTKgB1 by homologous recombination with a DNA fragment containing an intact HSV-1 TK gene. A TK ÷ virus was selected after enrichment in LTK-cells grown in HAT medium. This revertant, which did not synthesize BHV-1 gB, was neutralized by MAb H233 to the same extent as HSV-1 PAAr5 (Fig. 6) . These results confirm that BHV-1 gB is incorporated into the envelope of the pseudodiploid virus and that this glycoprotein is capable of complementing the role played by HSV-1 gB in initiating infection.
Discussion
The amino acid sequence of HSV-1 gB and possibly, to a greater extent, its tertiary structure (Pellett et al., 1985b) is strongly conserved among the members of Herpesviridae. The gB homologues of most herpesviruses are expressed abundantly on the surface of virions and infected cells and, at least in HSV, provide an important target for antibody (Eberle & Mou, 1983; Blacklaws et al., 1987; Glorioso et al., 1984) and cell-mediated immunity (Chanet al., 1989) . The conservation of the structure of the gB homologues, despite strong immunological selective pressure, suggests that the glycoproteins play a central role in the biology of herpesviruses. This is underscored by the observation that HSV-1 gB, and probably the other homologues, are essential for viral infectivity.
HSV-1 and BHV-1 gBs (Fitzpatrick et al., 1988) have the potential to fuse membranes and a role for these glycoproteins has been postulated in the entry of the virus into the host cell and the spread of virus between adjacent cells. The conserved nature of the glycoproteins and certain features of their structure suggest that gBmediated membrane fusion is a complex process. It is also possible that the gBs have other functions and properties as well.
Some gB homologues induce syncytia when expressed in the absence of other viral proteins (Ali et al., 1987; Fitzpatrick et al., 1988) . Despite this, cells infected with most strains of HSV-1 rarely form syncytia, whereas syn mutants, having a lesion that maps in gB, do. Evidence suggests that, in cells infected with HSV-1, the ability of gB to form syncytia is 'down-regulated' by another HSV-1 protein and that HSV-1 gB may interact with this protein through a domain(s) in its cytoplasmic aspect. Amino acids 816 to 817 and 858 are thought to form at least a portion of this domain (DeLuca et al., 1982; Cai et al., 1988b) .
gB has a complex transmembrane domain which may pass through the viral envelope or infected cell membranes three times (Pellett et al., 1985b; Claesson-Welsh & Spear, 1987) . The central segment of the domain forms a perfect amphipathic helix in which the positions of the hydrophilic amino acids are strongly conserved among the homologues. Although this arrangement may be needed for the formation of oligomers of gB molecules, it is also conceivable that the amphipathic helices of the gB molecules cooperate to form a hydrophilic pore in the infected cell membrane.
The testing of these and other hypotheses about gB function requires a systematic mutagenic analysis of the glycoprotein. Currently, a system for specifically examining directed mutations in gB is not available. HSV-1 gB is an essential protein and the isolation of mutants in certain domains of the protein has been difficult. In addition, although the study of plasmid-borne gB' mutants in cells infected with gB-nult HSV has identified some structural and functional domains of gB (Cai et al., 1988 a, b; Highlander et al., 1988) , this approach does not allow the mutant gene to be examined as an integral part of the virus.
One approach to overcoming this problem may be to use homologous, yet immunologically distinguishable, proteins from other herpesviruses to complement mutations in gB. By constructing pseudodiploid HSV-1, which in addition to containing its own gene for gB also contains the gene for BHV-1 gB, we have shown that this approach is feasible.
Cells infected with the pseudodiploid viruses and virions enriched by differential centrifugation and banding in potassium tartrate gradients contained both gB homologues. Although the purified virion preparations may not have been completely devoid of contaminating host cell membranes, they were enriched for virion proteins. For each pseudodiploid virus the ratio of radioactivity associated with HSV-1 gB and BHV-1 gB in the enriched virions was the same as in infected cells, suggesting that both gB homologues were incorporated into virion membranes with equal efficiency. Incorporation of BHV-1 gB into pseudodiploid virion membranes was supported by the inability of MAb H233 to neutralize completely the infectivity of the pseudodiploid virions.
Our results suggest that BHV-1 gB and HSV-I gB do not form hetero-oligomers in pseudodiploid virions or infected cells. Homo-oligomers of gBs (Claesson-Welsh & Spear, 1986; Sarmiento et al., 1979) and functional hetero-oligomers of gE and gI (Johnson et al., 1988) are not dissociated during the solubilization of membranes for immunoprecipitation; the glycoproteins are essentially immunoprecipitated as oligomers. They are disengaged when heated in SDS and 2-mercaptoethanol in preparation for SDS-PAGE. Although we can not completely rule out the association of HSV-1 gB and BHV-I gB in cell and virion membranes, had the two glycoproteins formed hetero-oligomers with the avidity that exists between homo-oligomers of gB, the MAbs would have precipitated both glycoproteins.
MAb H233, which selectively binds to HSV-1 gB and neutralizes the infectivity of HSV-1, was less able to neutralize the pseudodiploid viruses. The resistance to neutralization seemed to be related to the amount of BHV-1 gB produced by the pseudodiploid viruses. Thus, PsBHVgB-2, which made equivalent amounts of BHV-1 and HSV-1 gB, was almost completely resistant to neutralization, whereas PsBHVgB-1, which contained approximately 10-fold less BHV-1 gB, was less resistant. These results suggest that BHV-1 gB can complement those functions of HSV-I gB required in initiating infection which are neutralized by MAb H233. It is possible that HSV-I gB has other functions as well. To determine whether BHV-1 gB can complement these functions it is necessary to test the pseudodiploid viruses in a system in which the synthesis of HSV-1 gB can be aborted. To this end we are attempting to construct pseudodiploid viruses that have temperature-sensitive mutations in HSV-1 gB.
